Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence J Lesko

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|August 17, 2021
Perspective on model-informed drug developmentLawrence J Lesko
Clinical Pharmacology and Therapeutics|October 21, 2017
Efficacy From Strange SourcesLawrence J Lesko
Personalized Medicine|May 23, 2018
Pharmacogenetics in medicine: barriers, critical factors and a framework for dialogueIssam Zineh, Lawrence J Lesko
Nature Reviews. Drug Discovery|September 2, 2004
Translation of pharmacogenomics and pharmacogenetics: a regulatory perspectiveLawrence J Lesko, Janet Woodcock
Pharmacogenomics|March 31, 2010
DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDALawrence J Lesko, Issam Zineh
The New England Journal of Medicine|February 21, 2009
Pharmacogenetics--tailoring treatment for the outliersJanet Woodcock, Lawrence J Lesko
British Journal of Clinical Pharmacology|November 30, 2013
Clinical implementation of genetic testing in medicine: a US regulatory science perspectiveLawrence J Lesko, Stephan Schmidt
Pharmacogenomics|December 20, 2003
Pharmacogenomics in Drug Development and Regulatory Decision-making: the Genomic Data Submission (GDS) ProposalRonald A Salerno, Lawrence J Lesko
Pharmacogenomics|June 24, 2004
Pharmacogenomic data: FDA voluntary and required submission guidanceRonald A Salerno, Lawrence J Lesko
Journal of Clinical Pharmacology|May 18, 2004
Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned?Shiew-Mei Huang, Lawrence J Lesko
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
CPT: Pharmacometrics & Systems Pharmacology|August 17, 2021
Perspective on model-informed drug developmentLawrence J Lesko
Clinical Pharmacology and Therapeutics|October 21, 2017
Efficacy From Strange SourcesLawrence J Lesko
Personalized Medicine|May 23, 2018
Pharmacogenetics in medicine: barriers, critical factors and a framework for dialogueIssam Zineh, Lawrence J Lesko
Nature Reviews. Drug Discovery|September 2, 2004
Translation of pharmacogenomics and pharmacogenetics: a regulatory perspectiveLawrence J Lesko, Janet Woodcock
Pharmacogenomics|March 31, 2010
DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDALawrence J Lesko, Issam Zineh
The New England Journal of Medicine|February 21, 2009
Pharmacogenetics--tailoring treatment for the outliersJanet Woodcock, Lawrence J Lesko
British Journal of Clinical Pharmacology|November 30, 2013
Clinical implementation of genetic testing in medicine: a US regulatory science perspectiveLawrence J Lesko, Stephan Schmidt
Pharmacogenomics|December 20, 2003
Pharmacogenomics in Drug Development and Regulatory Decision-making: the Genomic Data Submission (GDS) ProposalRonald A Salerno, Lawrence J Lesko
Pharmacogenomics|June 24, 2004
Pharmacogenomic data: FDA voluntary and required submission guidanceRonald A Salerno, Lawrence J Lesko
Journal of Clinical Pharmacology|May 18, 2004
Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned?Shiew-Mei Huang, Lawrence J Lesko
Pageof 9